Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2007
09/05/2007EP1829549A1 Amorphous composition
09/05/2007EP1829544A1 Pharmaceutically active morpholinol
09/05/2007EP1828248A2 Compositions comprising anti-igf-1 receptor antibodies and methods for obtaining said antibodies
09/05/2007EP1828202A2 Rapamcyin analogues and the uses thereof in the treatment of neurologial proliferative and inflammatory disorders
09/05/2007EP1828200A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease.
09/05/2007EP1828199A1 Thieno-pyridine derivatives as gaba-b allosteric enhancers
09/05/2007EP1828188A1 Bridged ring nk1 antagonists
09/05/2007EP1828186A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors
09/05/2007EP1828182A2 Therapeutic pyrazolo[3,4-b]pyridines and indazoles
09/05/2007EP1828179A2 Nicotinic alpha-7 receptor ligands and preparation and uses thereof
09/05/2007EP1828176A1 Tetrahydroquinoline analogues as muscarinic agonists
09/05/2007EP1828173A1 Enentiomers of 3-heteroaryl-8h-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors
09/05/2007EP1828154A1 Phenyl-piperazin methanone derivatives
09/05/2007EP1828151A2 Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease
09/05/2007EP1828137A1 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
09/05/2007EP1828122A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
09/05/2007EP1828121A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
09/05/2007EP1828111A2 Methods and fluorinated compositions for treating amyloid-related diseases
09/05/2007EP1827476A2 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
09/05/2007EP1827468A2 Leuprolide acetate and acetylcholinesterase inhibitors or nmda receptor antagonists for the treatment of alzheimer's disease
09/05/2007EP1827461A1 Cladribine regimen for treating multiple sclerosis
09/05/2007EP1827431A1 Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury
09/05/2007EP1827427A1 Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
09/05/2007EP1827426A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
09/05/2007EP1827420A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
09/05/2007EP1827412A1 Compositions for use in surgery
09/05/2007EP1827410A2 Bis(thio-hydrazide amides) for increasing hsp70 expression
09/05/2007EP1827409A2 Rasagiline orally disintegrating compositions
09/05/2007EP1827385A2 Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
09/05/2007EP1684749B1 USE OF 1,3-DIAZA-DIBENZO[e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
09/05/2007EP1626709B1 Enantiomeric amphetamine compositions for the treatment of adhd
09/05/2007EP1569638B1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
09/05/2007EP1562570A4 Treatment of amyotrophic lateral sclerosis with nimesulide
09/05/2007EP1539802B1 Novel kcnq polypeptides and their uses in the diagnosis of mental disorders
09/05/2007EP1511507B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
09/05/2007EP1492796B1 Substituted amino isoxazoline derivatives and their use as anti-depressants.
09/05/2007EP1487811B1 N-sulfonylurea apoptosis promoters
09/05/2007EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007EP1345598B1 The use of rosiglitazone for treating psychiatric disorders.
09/05/2007EP1257551B1 Heterocyclic compounds and their use as parp inhibitors
09/05/2007EP0757716B1 Dna encoding bradykinin b1 receptor
09/05/2007CN101031567A Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof
09/05/2007CN101031563A Benzimidazole derivatives, composition containing thereof and its preparation and application
09/05/2007CN101031554A Benzoxazine and quinoxaline derivatives and uses
09/05/2007CN101031548A Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy) phenylmethyl) carbamide and their preparation
09/05/2007CN101031338A Compositions and methods for treating cognitive disorders
09/05/2007CN101031298A Medicine with analgesic function
09/05/2007CN101031296A Modulators of muscarinic receptors
09/05/2007CN101029337A Use and method for predicting serotonin re-uptake inhibitor medicine effect by polymorphic site
09/05/2007CN101029336A Reagent kit for predicting serotonin re-uptake inhibitor medicine effect
09/05/2007CN101029302A Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease
09/05/2007CN101029080A Methods and compositions for derepression of IAP-inhibited caspase
09/05/2007CN101029065A Bean-curd pectin analogue and its use in medicine for preventing depression
09/05/2007CN101029064A Bean-curd pectin analogues, and its use in preparation of medicine for preventing senile dementia
09/05/2007CN101029051A (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor
09/05/2007CN101029037A 2-benzo(C) foroxone compound, its production and use
09/05/2007CN101028500A Two-purpose food with appetising and sobering-up functions and its production
09/05/2007CN101028474A Method for inspecting the quality of Chinese preparation with Yang-and kidney tonifying functions
09/05/2007CN101028458A Tongluo Futan preparation
09/05/2007CN101028451A Chinese medicine for treating tic douloureux
09/05/2007CN101028448A Oral Chinese-medicinal composition for treating vascular neurologic migraine
09/05/2007CN101028352A Chinese-medicinal preparation for treating ischiodynia
09/05/2007CN101028350A Acupoint paste medicine for treating tic douloureux
09/05/2007CN101028344A Medicinal composition with corydalis and Radix Angelicae pubescentis, its production and use
09/05/2007CN101028341A Magnoliaceae plant extract, its production and use
09/05/2007CN101028327A Xie Bao oral liquid and its production
09/05/2007CN101028315A Chinese medicine for treating neuralgia
09/05/2007CN101028306A Chinese medicine for treating chronic dementia praecox
09/05/2007CN101028301A Chinese medicine for treating nerve hyposthenia, dizziness and syrigmus
09/05/2007CN101028265A Black and white medicinal composition for improving sleep and adjusting sleep-rhythm functions
09/05/2007CN101028237A Method for improving sleep behaviors
09/05/2007CN101028095A Ginseng mint
09/05/2007CN100335483C Double piperazine quaternary ammonium salt compound with analgetic function
09/05/2007CN100335479C Bicyclic inhibitors of glycogen synthase kinase 3
09/05/2007CN100335478C Chemokine receptor binding heterocyclic compounds
09/05/2007CN100335464C Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/05/2007CN100335136C Pharmaceutical composition having reduced tendency for drug crystallization
09/05/2007CN100335110C Extractive and its application in medicine
09/05/2007CN100335109C Process for preparing cell activation agent for treating motor nervous system disease
09/05/2007CN100335106C Traditional Chinese medicine composition for treating intelligence impairment and dementia and preparation method thereof
09/05/2007CN100335093C Head invigorating capsule and its preparation thereof
09/05/2007CN100335070C Coriolus versicolor zymolyte, its preparation method and use for adjuvant as alcoholic drink
09/05/2007CN100335066C Muscle refining extract, its preparation method and application
09/05/2007CN100335047C Aripiprazole complex formulation and method
09/05/2007CN100335037C Free-flowing, powdery composition containing alpha-liponic acid (-derivatives)
09/04/2007USRE39820 Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
09/04/2007US7265246 7-Aminoakyl-2-arylcarbonylaminoindanes, e.g., 3-Fluorobiphenyl-4-carboxylic acid (R)-(6-((3-ethoxypropylamino)methyl)-2R-hydroxyindan-1-yl)amide; treatment of cognitive impairment associated with schizophrenia, Alzheimer's disease, and psychoses
09/04/2007US7265245 Compounds useful for the treatment of diseases associated with the formation of amyloid fibrils
09/04/2007US7265228 N-(alpha-methylolbenzyl)1-(aminoethyl)- or 1-(aminocarbonyl)-2-aryl(especially phenyl or benzodioxanyl)-2-hydroxyethylamine intermediates for enantiomeric synthesis of amino ceramide-like compounds
09/04/2007US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity
09/04/2007US7265226 Interact with opoid receptors; decreasing metabolic rates of the phenolic piperidines by amidation, imidation, or forming a formamide, a hydroxyamidine or a thioamide; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction
09/04/2007US7265221 Pyrrolo[2,3-d]pyrimidine compounds
09/04/2007US7265208 Autoimmune disease; allergies vaccine
09/04/2007US7265151 Treatment of neurotic disorders
09/04/2007US7265146 Administering small molecule compounds, especially acids or esters, that inhibit the interaction between alpha 4 integrins and ligands MAdCAM and/or VCAM for treatment of chronic inflammatory diseases such as arthritis, asthma, multiple sclerosis, Chrohn's disease, ulcerative colitis, and hepatitis C
09/04/2007US7265137 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders
09/04/2007US7265135 Antihistamines; cognition activators; Alzheimer's disease; antiepileptic agents; eating disorders; motion sickness; psychological disorders
09/04/2007US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases
09/04/2007US7265127 Imidazo[1,2-a]pyridine derivatives, especially N-(2-(8-(3-aminocarbonyl-2-pyridyloxy)imidazo[1,2-a]pyrid-3-yl)-1,1-dimethylethyl)-3-(o-isoxazol-3-ylphenoxy)-2-hydroxypropylamine; treating type-2 diabetes and obesity
1 ... 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 ... 1833